Sanofi Bets on mRNA Vaccines After Covid-19 Pandemic Shows Worth

Sanofi, one of the world’s biggest vaccine makers, plans to invest some $477 million a year to catch up in the new gene-based technology.

Facebook Acquisition Review Shows EU’s New Antitrust Power

The company has hit a new obstacle in Europe for its...

Activision Replaces Blizzard Head as It Grapples With Gender-Bias Lawsuit

A California agency accused executive J. Allen Brack and others at...

Alibaba Posts Quarterly Profit Lifted by E-Commerce and Cloud Computing

The tech giant’s profit attributable to shareholders was about $6.99 billion...

American Dream Aims to Ride Luxury Wave

The sprawling shopping mall and entertainment center outside Manhattan is opening...